Validation of BET Platforms and Product Samples:

What is Required and What are Some of the Common Challenges?

Previously Aired on May 25th, 2021

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

  Register

Overview

What has your experience with endotoxin systems and product validation been like? In this webinar, we will look at what steps are needed for a new platform to be considered fully validated, and we’ll dive into some of the challenges that the typical Quality Control lab may experience.

Then, we'll discuss what the optimal validation process looks like and how an organization can save time and resources using the Sievers Eclipse BET Platform. Finally, we’ll explain how the platform simplifies and streamlines validation of product samples and wrap up by showcasing some of the software’s most convenient features. Getting a validated, automated system deployed has never been so easy.

In this webinar, you will learn why endotoxin product validation has traditionally been challenging and how a new bacterial endotoxins testing platform can eliminate some common complexities. You’ll also learn about the requirements for a fully validated system, and what the ideal validation scenario looks like.

Who should attend:

  • QC Analysts
  • QC Managers
  • QC supervisors
  • Metrology
  • Validation engineers 

Presenters

Presenter
Sydney Jannetta
(Presenter)
Product Application Specialist, Life Sciences
SUEZ
View Biography
Presenter
Brian Short
(Presenter)
Global Pharmaceutical Application Specialist
SUEZ
View Biography
Presenter
Mike Auerbach
(Moderator)
Editor-in-Chief,
American Pharmaceutical Review